{
  "docId": "019de076-e431-717d-85d5-60fbb8c86744",
  "docSlug": "9614dd2dbfdf83d72e770ebfe5753af3",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 42,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a timeline-based structure to demonstrate operational momentum.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-e431-717d-85d5-60fbb8c86744/5",
  "deckHref": "/decks/019de076-e431-717d-85d5-60fbb8c86744",
  "deckJsonHref": "/decks/019de076-e431-717d-85d5-60fbb8c86744.json",
  "deckAnchorHref": "/decks/019de076-e431-717d-85d5-60fbb8c86744#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.205
      },
      "kind": "callout",
      "text": "Resource-efficient execution and value creation across an expanding portfolio of wholly-owned programs",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5542fd18-2252-469c-a108-350e1b921f73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.36,
        "y": 0.36
      },
      "kind": "list",
      "text": "2022 FIRST CLINICAL PROOF-OF-CONCEPT: Initiated two global Phase 1/2 studies, Demonstrated clinical proof-of-concept for ROS1 program, Disclosed third novel program",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b366639-54f7-400b-b617-a61ed049f55f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.66,
        "y": 0.36
      },
      "kind": "list",
      "text": "2023 SECOND PROOF-OF-CONCEPT & FIRST PIVOTAL STUDY: Demonstrated clinical proof-of-concept for ALK program, Initiated ARROS-1 Phase 2, Advanced HER2 program",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c012d253-fbb3-49fc-8637-0843c784ddaf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.06,
        "y": 0.36
      },
      "kind": "list",
      "text": "2021 EMERGENCE FROM STEALTH: Disclosed parallel lead programs, Presented preclinical profiles, Nasdaq listed: NUVL",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fbfbd3eb-b10c-4848-977c-f90b5375dfad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.7,
        "x": 0.15,
        "y": 0.79
      },
      "kind": "paragraph",
      "text": "Ended 2023 with approximately $719.9M* in cash, cash equivalents and marketable securities (unaudited), with potential to deliver multiple transformative catalysts within cash runway window into 2027",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab154e66-cb49-41a0-8d81-837227f69c50",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.05,
        "y": 0.885
      },
      "kind": "source-note",
      "text": "* Preliminary, unaudited estimate only as of the date of this presentation; subject to change following completion of year-end closing procedures; does not present all information necessary for an understanding of financial position as of December 31, 2023.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41b651e6-5a27-4fdb-8639-37f044fe8e14",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.36,
        "x": 0.32,
        "y": 0.1
      },
      "kind": "title",
      "text": "Track Record of Success",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9636500b-c6be-48e9-bc27-ca5c9c54e478",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "7b2211aa-15f0-4eb3-b933-2ee2ad7c8053",
      "evidence": "Chronological presentation of milestones from 2021-2023",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}